ARWR
USDArrowhead Pharmaceuticals Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$19.050
High
$19.325
Low
$16.670
Volume
1.45M
Company Fundamentals
Market Cap
2.6B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.66M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
- Zodasiran targets ANGPLT3, an emerging therapeutic target to treat HoFH and other dyslipidemias - YOSEMITE Phase 3 study further enhances Arrowhead's late-stage pipeline of RNAi-based cardiometabolic
Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
- Study completion anticipated in mid-2026 with subsequent data readout and regulatory submissions for treatment of severe hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has
Related Stocks
NNOX
NANO-X IMAGING LTD Ordinary Shares
SOHOO
Sotherly Hotels Inc. 7.875% Series C Cumulative Redeemable Perpetual Preferred Stock
KMT
Kennametal Inc.
CEG
Constellation Energy Corporation
RAIL
FreightCar America Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.